Pillar Pacific Capital Management’s Protara Therapeutics TARA Stock Holding History

Pillar Pacific Capital Management’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-287	Closed	-$21K	–	307
2016 Q4	$21K	Hold	287	–	–	﹤0.01%	301
2016 Q3	$107K	Hold	287	–	–	0.02%	295
2016 Q2	$92K	Hold	287	–	–	0.02%	293
2016 Q1	$89K	Hold	287	–	–	0.02%	292
2015 Q4	$178K	Hold	287	–	–	0.03%	278
2015 Q3	$159K	Hold	287	–	–	0.03%	279
2015 Q2	$205K	Hold	287	–	–	0.04%	271
2015 Q1	$134K	Buy	+287	New	+$126K	0.02%	278

Other funds holding TARA

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Pillar Pacific Capital Management's TARA Position: Q1 2017 in Review

Pillar Pacific Capital Management sold out of Protara Therapeutics (TARA) in Q1 2017, closing a stake of 287 shares — an estimated $21K sold.

Pillar Pacific Capital Management first reported a position in TARA in Q1 2015 and held it in 8 quarters. The position peaked at $205K in Q2 2015. 28 funds tracked by Wall St. Rank hold TARA as of Q1 2017.

Pillar Pacific Capital Management reported no remaining Protara Therapeutics position as of Q1 2017 after selling out during the quarter.
Pillar Pacific Capital Management sold 287 Protara Therapeutics shares in Q1 2017, an estimated $21K.
Pillar Pacific Capital Management first reported a position in Protara Therapeutics in Q1 2015 and held it in 8 quarters.
Pillar Pacific Capital Management's Protara Therapeutics position peaked at $205K in Q2 2015.
28 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2017.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2017, filed 2 May 2017.